Ativan usually stays detectable in urine for 1–7 days after the last dose. In one controlled study, a single 2.5 mg oral dose was detectable in urine for 144 hours, or 6 days. Saliva testing showed a much shorter window of about 8 hours, while hair testing did not detect a single dose 4 weeks later in that study (ARUP Consult, 2025; Kintz et al., 2004).
Ativan is the brand name for lorazepam, a prescription benzodiazepine used for anxiety disorders and short-term anxiety relief. After an oral dose, it reaches peak blood levels in about 2 hours. The average Ativan half-life is about 12 hours, and its main inactive metabolite has an average half-life of about 18 hours before being removed in urine (DailyMed, 2025).
Key Takeaways
- Urine testing commonly detects Ativan for 1–7 days. ARUP lists a 1–7 day urine detection window and a 9–16 hour drug half-life estimate for this medication (ARUP Consult, 2025).
- In one controlled study, a single 2.5 mg dose was detectable in urine for 144 hours. That means detection lasted up to six days, with peak urine levels around 24 hours (Kintz et al., 2004).
- Oral use usually peaks in the blood around 2 hours after dosing. Calming or sedating effects may fade before the medication is no longer detectable (DailyMed, 2025).
- Saliva testing usually has a short window. One study found oral fluid positive for 8 hours after a single 2.5 mg dose (Kintz et al., 2004).
- Hair testing may not capture one-time use. The same controlled study could not detect Ativan in hair 4 weeks after a single dose (Kintz et al., 2004).
- Some urine screens can miss Ativan because the main urinary metabolite may react poorly with standard immunoassays (Lund et al., 2023; Uljon et al., 2025).
- Newer benzodiazepine immunoassays can improve detection of the glucuronide metabolite. LC-MS/MS may still be needed when results are unexpected or used for compliance monitoring (Ge et al., 2024; Tolan et al., 2024).
- A valid prescription can help explain a positive result. Confirmatory testing may still be needed to identify the specific substance (Uljon et al., 2025).
- Stopping suddenly after regular use can cause withdrawal. Tapering guidance often starts with 5% to 10% dose reductions every 2–4 weeks (Brunner et al., 2025).
- Combining benzodiazepines with opioids raises serious safety risk. One BMJ study found more than double the odds of opioid-related emergency care or inpatient admission during concurrent use (Sun et al., 2017).
- Benzodiazepines can cause misuse, addiction, and physical dependence even when taken as prescribed. FDA warns that risk increases when combined with opioids or alcohol (FDA, 2020).
Ativan Detection Times by Test Type
| Test Type | Typical Detection Window | What It Usually Shows |
| Urine | 1–7 days | Recent use over several days |
| Blood | Usually recent use | Current or recent exposure |
| Saliva | Up to 8 hours in one study | Short-term exposure |
| Hair | Variable | Longer-term exposure pattern |
Detection windows are estimates. Results can vary based on dose, timing, and cutoff. ARUP notes that detection limits vary by assay, so laboratories should be consulted about specific testing methods (ARUP Consult, 2025).
Urine is usually the main concern because Ativan and its metabolite are removed through urine. In one controlled study, lorazepam was found in urine for 144 hours after a single 2.5 mg oral dose. Oral fluid had a shorter 8-hour positive window in the same study (Kintz et al., 2004).
Free, Confidential Helpline
Ready to take the next step toward recovery?
Our Recovery Advocates are available around the clock to answer your questions, verify your insurance, and help you find the right level of care — at no cost to you.
Quick Answer: How Long Does Ativan Stay in Your System?
For most people, the practical answer is several days after the last dose. Urine testing usually has the longest common detection window for recent use, with ARUP listing 1–7 days (ARUP Consult, 2025).
The noticeable effects do not last as long as the testing window. You may no longer feel sedated, but a urine screen may still identify Ativan or its metabolite. This happens because the body processes the drug and removes it through urine (DailyMed, 2025).
Detection may last longer after repeated use or higher doses. One low dose may clear sooner, but the exact timeline depends on the test method and cutoff (ARUP Consult, 2025).
Ativan Timeline: Onset, Peak, Duration and Detection
| Timeline Point | Typical Timing | What It Means |
| Starts working | Often within the first hour | Calming or sedating effects may begin |
| Peaks in blood | About 2 hours | Blood concentration is usually highest |
| Noticeable effects | Several hours | Sedation and slower reaction time may continue |
| Clearance marker | About 12 hours | Blood levels decline over time |
| Urine detection | 1–7 days | Common testing window for recent use |
Oral dosing reaches peak plasma concentration around 2 hours after administration. ARUP lists the urine detection window at 1–7 days (DailyMed, 2025; ARUP Consult, 2025).
This timeline separates how the dose feels from how long it can be found. The strongest effects may wear off within several hours, while detection may continue for days.
What Is Ativan Used For?
This medication is used for anxiety disorders and short-term relief of anxiety symptoms. It belongs to the benzodiazepine class, which acts on the central nervous system and can produce calming or sedating effects (DailyMed, 2025).
DailyMed notes that effectiveness for long-term use beyond 4 months has not been assessed in systematic clinical studies. A prescriber should periodically reassess whether ongoing use is still appropriate (DailyMed, 2025).
How Long Does Ativan Take To Kick In?
Oral use reaches peak plasma concentration around 2 hours after a dose. Some people feel calming or sedation earlier (DailyMed, 2025).
Timing can vary by dose, age, and other medicines. Sedation can affect driving or work tasks that require alertness. DailyMed warns patients not to drive or operate heavy machinery until they know how they respond (DailyMed, 2025).
How Long Do Ativan Effects Last?
Noticeable effects often last several hours. Some people may continue to feel sleepy or less coordinated after the strongest point has passed. DailyMed lists sedation, dizziness, and unsteadiness among common adverse reactions (DailyMed, 2025).
Feeling normal again does not always mean the body has fully cleared the medication. Testing can still identify exposure after the calming sensation is gone (ARUP Consult, 2025; DailyMed, 2025).
Older adults may be more sensitive to sedation. DailyMed reports that one study found total body clearance decreased by 20% in older adults after single intravenous doses (DailyMed, 2025).
How the Body Processes Ativan
After oral use, the active ingredient is readily absorbed. DailyMed lists oral bioavailability at about 90%, with peak plasma concentrations around 2 hours after administration (DailyMed, 2025).
The body converts it into lorazepam glucuronide, an inactive metabolite that is excreted in urine (DailyMed, 2025).
This matters for testing because some screens look for a broad benzodiazepine class. Others identify specific substances. A screen that does not detect the glucuronide metabolite well may miss use (Lund et al., 2023; Uljon et al., 2025).
Ativan Drug Half-Life
A drug’s half-life is the time it takes the body to reduce the amount in the blood by half.
This clearance timeline helps explain why Ativan can remain detectable after the noticeable effects fade. The average half-life is about 12 hours. The major inactive metabolite averages about 18 hours (DailyMed, 2025).
Many substances take several elimination cycles to mostly clear. ARUP notes that five such cycles are generally required for elimination, though detection varies by assay and patient factors (ARUP Consult, 2025).
Does Ativan Show Up on Drug Tests?
Ativan can show up on a drug screening as a benzodiazepine. The result depends on the test method.
Many initial urine screens use immunoassays. These are fast, but they do not detect every benzodiazepine equally well. False negatives are possible because the main urinary metabolite may react poorly with some commercial assays (Lund et al., 2023; Uljon et al., 2025).
Lab research shows that benzodiazepines excreted as glucuronidated metabolites can cross-react poorly with standard FDA-cleared immunoassays. A 2025 clinical report found that a patient taking prescribed Ativan had a negative immunoassay screen but tested positive by LC-MS/MS for lorazepam glucuronide (Lund et al., 2023; Uljon et al., 2025).
If a result is unexpected, confirmatory testing such as LC-MS/MS can identify specific substances more accurately (Uljon et al., 2025; Tolan et al., 2024).
False Positives and False Negatives
Ativan testing can be confusing because screening methods are limited.
A false positive means the screen suggests benzodiazepine use, but confirmatory testing may not verify it. A false negative means the screen misses a substance that is present. This is especially relevant when the glucuronide metabolite is poorly detected by the assay (Lund et al., 2023; Uljon et al., 2025).
Newer immunoassays that include beta-glucuronidase can improve sensitivity for this metabolite. Even so, research on the Roche Benzodiazepines II assay found that mass spectrometry may still be needed for some patients, especially when monitoring compliance (Ge et al., 2024; Tolan et al., 2024).
What if You Have a Prescription?
A valid prescription can help explain a positive benzodiazepine result. Follow the testing program’s instructions for reporting prescribed medicines.
Stopping suddenly to prepare for a drug test can be risky. FDA warns that benzodiazepines can cause physical dependence and withdrawal reactions. The 2025 Joint Clinical Practice Guideline recommends gradual tapering when risks outweigh benefits (FDA, 2020; Brunner et al., 2025).
If a result does not match your prescription history, ask whether confirmatory testing is available. This can identify the specific drug rather than only reporting a general benzodiazepine screen (Uljon et al., 2025).
How Long Does Ativan Stay in Urine?
Urine testing commonly finds recent use for 1–7 days, according to ARUP’s detection window (ARUP Consult, 2025).
A controlled study found a 144-hour urine detection period after one 2.5 mg oral dose. Peak urine concentrations occurred around 24 hours. This means a single dose may remain detectable for about five days or longer in some testing situations (Kintz et al., 2004).
Regular use, higher doses, and lower cutoffs can extend the window. One low dose may clear sooner. ARUP notes that detection windows are estimates and that many factors can affect results (ARUP Consult, 2025).
How Long Does Ativan Stay in Blood?
Blood testing usually reflects current or recent exposure. It is less common than urine testing for routine screening.
Oral dosing peaks in plasma around 2 hours. Blood levels then decline according to the pharmacokinetic timeline described by DailyMed (DailyMed, 2025).
A blood sample may be used when timing or impairment is the main concern. The exact testing window depends on the assay and clinical situation (ARUP Consult, 2025).
How Long Does Ativan Stay in Saliva?
Saliva testing usually has a shorter detection window than urine testing.
In one small controlled study, oral fluid tested positive for 8 hours after a single 2.5 mg oral dose (Kintz et al., 2004).
Because saliva windows can be short, urine testing is often more useful when the goal is to document exposure over several days. Confirmatory lab testing may also be needed when results are unclear (ARUP Consult, 2025).
How Long Does Ativan Stay in Hair?
Hair testing can show longer-term exposure patterns for some substances, but it may not reliably detect a single dose.
In one controlled study, researchers could not detect the substance in hair 4 weeks after exposure. Urine and oral fluid were positive earlier in the same study (Kintz et al., 2004).
Hair results depend on the lab method, timing, and exposure pattern. ARUP also notes that detection windows are estimates and that detection limits vary by assay (ARUP Consult, 2025).
Factors That Affect How Long Ativan Stays in Your System
Several factors can change how long Ativan remains detectable:
- Dose: Higher doses may take longer to clear.
- Frequency: Repeated use can extend the detection window.
- Timing: A test taken soon after use is more likely to be positive.
- Test type: Urine usually detects recent use longer than blood or saliva.
- Test cutoff: Lower cutoffs can detect smaller amounts for longer.
- Test method: Some immunoassays may miss the substance unless confirmatory testing is used.
- Health status: Age, kidney health, and liver health may affect medication handling.
- Other substances: Alcohol, opioids, and sedatives can increase safety risks.
Detection windows are estimates, and ARUP advises that many factors can affect detection numbers. DailyMed also notes that the substance is metabolized to a glucuronide metabolite and excreted in urine, which helps explain why urine testing is commonly used for recent exposure (ARUP Consult, 2025; DailyMed, 2025).
Can You Get Ativan Out of Your System Faster?
There is no reliable way to quickly clear Ativan from your system. The body needs time to metabolize and excrete it through urine (DailyMed, 2025).
Detox drinks and excessive water intake do not reliably change the biological window. Detection depends on assay limits, cutoff, and timing (ARUP Consult, 2025).
The safest approach is to take Ativan only as prescribed. If testing is required, follow the program’s disclosure process for prescription medications.
Ativan Side Effects
Ativan slows the central nervous system. This can reduce anxiety, but it can also impair alertness and coordination. DailyMed identifies this benzodiazepine as an antianxiety agent with central nervous system tranquilizing effects (DailyMed, 2025).
Common side effects may include:
- Sedation
- Dizziness
- Unsteadiness
- Tiredness
- Slowed reaction time
- Memory problems
DailyMed reports sedation, dizziness, and unsteadiness among common adverse reactions in people treated for anxiety (DailyMed, 2025).
Ativan, Alcohol and Opioids
This benzodiazepine can be dangerous when mixed with alcohol, opioids, or other sedatives. These substances can intensify central nervous system depression. FDA warns that benzodiazepine misuse can result in overdose, especially when combined with opioids or alcohol (FDA, 2020).
DailyMed warns that benzodiazepines used with opioids may cause profound sedation, respiratory depression, coma, and death (DailyMed, 2025).
A large BMJ study of privately insured patients found higher risk when opioids and benzodiazepines were used together. Concurrent use was associated with an adjusted odds ratio of 2.14 for opioid-related emergency care or inpatient admission (Sun et al., 2017).
Avoid mixing this drug with alcohol or other sedating substances unless a healthcare professional specifically says it is safe.
Ativan Withdrawal
Withdrawal can happen after regular use, especially when the dose is stopped suddenly or reduced too quickly.
FDA warns that benzodiazepines can cause physical dependence when taken steadily for several days to weeks, even as prescribed. FDA also advises using a gradual taper to discontinue benzodiazepines or reduce the dosage (FDA, 2020).
The 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering notes that abrupt discontinuation or rapid dose reduction can cause serious symptoms. The guideline recommends individualized tapering when dependence is likely (Brunner et al., 2025).
Possible symptoms include anxiety, insomnia, and tremor. More serious symptoms can include panic attacks, severe agitation, or seizures.
If you take this prescription regularly, talk with a healthcare professional before changing your dose.
Ativan Detox and Tapering
Detox should be medically supervised when physical dependence is possible. A gradual taper can lower the risk of severe symptoms (FDA, 2020; Brunner et al., 2025).
The 2025 Joint Clinical Practice Guideline states that initial tapering often includes dose reductions of 5% to 10% every 2–4 weeks. The guideline also says tapering should typically not exceed 25% every 2 weeks (Brunner et al., 2025).
The right schedule depends on dose, duration of use, and symptoms. Some people need a slower plan (Brunner et al., 2025).
Ativan Misuse and Addiction
Ativan contains lorazepam, a Schedule IV controlled substance. It has accepted medical uses, but it also carries risks of misuse, physical dependence, and addiction (DailyMed, 2025; FDA, 2020).
Misuse means using the drug in a way other than prescribed. This can include taking higher doses, using someone else’s prescription, or mixing it with alcohol. FDA warns that misuse and addiction can occur even at recommended dosages (FDA, 2020).
Addiction is different from physical dependence. Addiction involves cravings, loss of control, and continued use despite harm.
Signs of Ativan Addiction
Possible signs of addiction may include:
- Taking more than prescribed
- Running out early
- Cravings
- Doctor shopping
- Using someone else’s prescription
- Mixing benzodiazepines with alcohol or opioids
- Memory problems or blackouts
- Symptoms between doses
- Continued use despite health problems
FDA warns that benzodiazepines carry risks of abuse, misuse, and addiction. A person can be physically dependent without having addiction, but both situations can require medical support (FDA, 2020).
Ativan Overdose Signs
An overdose can be life-threatening, especially when benzodiazepines are combined with alcohol or opioids. Call 911 if severe symptoms are suspected.
Warning signs may include extreme sleepiness, confusion, and slurred speech. More serious signs include slow breathing, loss of consciousness, or coma.
DailyMed warns that benzodiazepines used with opioids may cause profound sedation, respiratory depression, coma, and death. FDA also warns that misuse can result in serious harm, especially when combined with opioids or alcohol (DailyMed, 2025; FDA, 2020).
Benzodiazepine Addiction Treatment
Addiction treatment may be needed when use becomes hard to control, causes dependence symptoms, or continues despite harm.
Care may include medical evaluation, supervised detox, and therapy. Ongoing treatment may also include tapering support, mental health care, and recovery planning.
Medical supervision is important because stopping too quickly can be dangerous. FDA advises gradual tapering for benzodiazepine discontinuation. The 2025 Joint Clinical Practice Guideline recommends individualized treatment plans based on risk, symptoms, and response (FDA, 2020; Brunner et al., 2025).
Ativan Addiction Treatment in Washington
The Recovery Village Ridgefield provides addiction treatment for adults in Washington and the Pacific Northwest. Care may include medical detox, inpatient rehab, and therapy.
Professional treatment can help people manage safety risks and address co-occurring anxiety symptoms. Medical support is especially important when benzodiazepine dependence is possible because stopping too quickly can cause serious symptoms (Brunner et al., 2025).
If Ativan use is affecting your health, safety, or relationships, help is available. A confidential conversation with a Recovery Advocate can help you understand treatment options.
Frequently Asked Questions
How long does Ativan stay in your system?
Ativan is commonly detectable in urine for 1–7 days. Blood and saliva usually show more recent use. Hair testing may reflect longer-term exposure patterns, but it is less reliable for a single dose (ARUP Consult, 2025; Kintz et al., 2004).
How long does Ativan stay in urine?
ARUP Consult lists the medication as detectable in urine for 1–7 days. One controlled study found urine detection across a 144-hour period after a single 2.5 mg dose (ARUP Consult, 2025; Kintz et al., 2004).
How long does Ativan take to work?
Oral dosing reaches peak plasma concentration around 2 hours. Some people feel calming or sedation before that point (DailyMed, 2025).
What is Ativan’s half-life?
The average half-life is about 12 hours. The main inactive metabolite averages about 18 hours (DailyMed, 2025).
Will Ativan show up on a drug test?
Yes, it can show up as a benzodiazepine. Some standard urine immunoassays may miss it because they do not detect the glucuronide metabolite well. Confirmatory testing can identify it more accurately (Lund et al., 2023; Uljon et al., 2025).
Can a prescription explain a positive result?
Yes. A valid prescription can help explain a positive benzodiazepine result. If the result is unexpected, confirmatory testing may help identify the specific substance (Uljon et al., 2025).
Can you flush Ativan out faster?
No reliable method clears it faster. The body needs time to metabolize and excrete it. Detection also depends on timing, cutoff, and test method (DailyMed, 2025; ARUP Consult, 2025).
Is it safe to stop Ativan suddenly?
Stopping suddenly after regular use can cause withdrawal symptoms, including seizures. Benzodiazepine tapering guidance often starts with 5% to 10% reductions every 2–4 weeks when clinically appropriate (Brunner et al., 2025).
When should someone seek help?
Seek help if use feels hard to control, involves alcohol or opioids, or continues despite harm. Call 911 right away if severe sedation or breathing problems appear. FDA warns that benzodiazepine misuse can result in serious harm, especially when combined with opioids or alcohol (FDA, 2020).
References
ARUP Consult. (2025). Drug half-lives and urine detection windows. ARUP Laboratories. Full hyperlink: https://arupconsult.com/content/drug-half-lives-and-urine-detection-windows
Brunner, E., Chen, C.-Y. A., Klein, T., Maust, D. T., Mazer-Amirshahi, M., et al. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when risks outweigh benefits. Journal of General Internal Medicine. Full hyperlink: https://pmc.ncbi.nlm.nih.gov/articles/PMC12463801/
DailyMed. (2025). Lorazepam tablet: Prescribing information. U.S. National Library of Medicine. Full hyperlink: https://www.dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8cb6b6e8-66ff-46f1-e053-2a95a90a3fd3&type=display
Food and Drug Administration. (2020). FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class. Full hyperlink: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
Ge, M., Alabi, A., Kelner, M. J., Fitzgerald, R. L., & Suhandynata, R. T. (2024). Evaluation of a benzodiazepine immunoassay for urine drug testing in clinical specimens. The Journal of Applied Laboratory Medicine, 9(6), 964–976. Full hyperlink: https://doi.org/10.1093/jalm/jfae083
Kintz, P., Villain, M., Cirimele, V., Pépin, G., & Ludes, B. (2004). Windows of detection of lorazepam in urine, oral fluid and hair, with a special focus on drug-facilitated crimes. Forensic Science International, 145(2–3), 131–135. Full hyperlink: https://doi.org/10.1016/j.forsciint.2004.04.027
Lund, K., Menlyadiev, M., Lee, K., Kelner, M. J., Fitzgerald, R. L., & Suhandynata, R. T. (2023). Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens. Journal of Mass Spectrometry and Advances in the Clinical Lab, 28, 91–98. Full hyperlink: https://doi.org/10.1016/j.jmsacl.2023.02.010
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017). Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis. BMJ, 356, j760. Full hyperlink: https://doi.org/10.1136/bmj.j760
Tolan, N. V., Uljon, S., Donnelly-Morell, M. L., Zhao, M., Mahowald, G. K., Snyder, M. L., Contella, L., Urwiller, E. D., Daluz Fernandes, M., Kang, P., & Melanson, S. E. F. (2024). Despite the improved clinical sensitivity of the Roche benzodiazepines II assay, it cannot replace mass spectrometry in all patient populations. Journal of Mass Spectrometry and Advances in the Clinical Lab, 33, 14–20. Full hyperlink: https://doi.org/10.1016/j.jmsacl.2024.06.002
Uljon, S., Donnelly-Morell, M. L., Tolan, N., & Melanson, S. E. F. (2025). Is my patient diverting their lorazepam? The Primary Care Companion for CNS Disorders, 27(2), 24cr03889. Full hyperlink: https://doi.org/10.4088/PCC.24cr03889
